CAH
Price
$138.74
Change
+$1.61 (+1.17%)
Updated
Apr 2, 02:42 PM (EDT)
Capitalization
27.26B
29 days until earnings call
COR
Price
$278.33
Change
+$0.92 (+0.33%)
Updated
Apr 2, 02:51 PM (EDT)
Capitalization
48.42B
28 days until earnings call
Ad is loading...

CAH vs COR

Header iconCAH vs COR Comparison
Open Charts CAH vs CORBanner chart's image
Cardinal Health
Price$138.74
Change+$1.61 (+1.17%)
Volume$781
Capitalization27.26B
Cencora
Price$278.33
Change+$0.92 (+0.33%)
Volume$400
Capitalization48.42B
CAH vs COR Comparison Chart
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. COR commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and COR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CAH: $137.13 vs. COR: $277.41)
Brand notoriety: CAH and COR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 93% vs. COR: 78%
Market capitalization -- CAH: $27.26B vs. COR: $48.42B
CAH [@Medical Distributors] is valued at $27.26B. COR’s [@Medical Distributors] market capitalization is $48.42B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileCOR’s FA Score has 4 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • COR’s FA Score: 4 green, 1 red.
According to our system of comparison, COR is a better buy in the long-term than CAH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 5 TA indicator(s) are bullish while COR’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 5 bullish, 3 bearish.
  • COR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CAH is a better buy in the short-term than COR.

Price Growth

CAH (@Medical Distributors) experienced а +3.68% price change this week, while COR (@Medical Distributors) price change was +3.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.51%. For the same industry, the average monthly price growth was -5.62%, and the average quarterly price growth was -8.08%.

Reported Earning Dates

CAH is expected to report earnings on May 01, 2025.

COR is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Distributors (-1.51% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($48.4B) has a higher market cap than CAH($27.3B). CAH has higher P/E ratio than COR: CAH (44.47) vs COR (26.47). COR YTD gains are higher at: 23.747 vs. CAH (16.873). COR has higher annual earnings (EBITDA): 3.71B vs. CAH (1.89B). CAH has more cash in the bank: 4.59B vs. COR (2.87B). CAH (4.72B) and COR (4.78B) have identical debt. COR has higher revenues than CAH: COR (272B) vs CAH (216B).
CAHCORCAH / COR
Capitalization27.3B48.4B56%
EBITDA1.89B3.71B51%
Gain YTD16.87323.74771%
P/E Ratio44.4726.47168%
Revenue216B272B79%
Total Cash4.59B2.87B160%
Total Debt4.72B4.78B99%
FUNDAMENTALS RATINGS
CAH vs COR: Fundamental Ratings
CAH
COR
OUTLOOK RATING
1..100
1118
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
9911
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
9013
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (59) in the Medical Distributors industry is somewhat better than the same rating for COR (96) in the Real Estate Investment Trusts industry. This means that CAH’s stock grew somewhat faster than COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is in the same range as CAH (3) in the Medical Distributors industry. This means that COR’s stock grew similarly to CAH’s over the last 12 months.

COR's SMR Rating (11) in the Real Estate Investment Trusts industry is significantly better than the same rating for CAH (99) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than CAH’s over the last 12 months.

COR's Price Growth Rating (5) in the Real Estate Investment Trusts industry is in the same range as CAH (9) in the Medical Distributors industry. This means that COR’s stock grew similarly to CAH’s over the last 12 months.

COR's P/E Growth Rating (13) in the Real Estate Investment Trusts industry is significantly better than the same rating for CAH (90) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHCOR
RSI
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 7 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 3 days ago
61%
Declines
ODDS (%)
Bearish Trend 24 days ago
48%
Bearish Trend 22 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBS1.490.05
+3.47%
Intelligent Bio Solutions
SNAP8.930.22
+2.53%
Snap
GEOS7.260.05
+0.69%
Geospace Technologies Corp
NWL6.18-0.02
-0.32%
Newell Brands
RCUS7.71-0.14
-1.78%
Arcus Biosciences

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-0.10%
COR - CAH
53%
Loosely correlated
-0.24%
MCK - CAH
45%
Loosely correlated
+0.10%
OMI - CAH
21%
Poorly correlated
+0.11%
SHTDF - CAH
12%
Poorly correlated
N/A
EDAP - CAH
8%
Poorly correlated
N/A
More

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
-0.24%
MCK - COR
60%
Loosely correlated
+0.10%
CAH - COR
52%
Loosely correlated
-0.10%
OMI - COR
22%
Poorly correlated
+0.11%
SHTDF - COR
17%
Poorly correlated
N/A
HSIC - COR
15%
Poorly correlated
+0.85%
More